Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis [0.03%]
与华法林相比，对于房颤患者处方阿哌沙班或利伐沙班是否能节约卫生系统成本？一项多值处理效应分析
Michael Situ,Ute I Schwarz,Guangyong Zou et al.
Michael Situ et al.
Background: Non-valvular atrial fibrillation (AF) is a common heart arrhythmia in the elderly population. AF patients are at high-risk of ischemic strokes, but oral anticoagulant (OAC) therapy reduces such risks. Warfarin...
Heteroscedasticity of residual spending after risk equalization: a potential source of selection incentives in health insurance markets with premium regulation [0.03%]
剩余支出的异方差性：具有保费监管的健康保险市场中产生选择激励的一个潜在来源
Michel Oskam,Richard C van Kleef,Rudy Douven
Michel Oskam
Many community-rated health insurance markets include risk equalization (also known as risk adjustment) to mitigate risk selection incentives for competing insurers. Empirical evaluations of risk equalization typically quantify selection in...
Primary care services and emergency department visits in blended fee-for-service and blended capitation models: evidence from Ontario, Canada [0.03%]
加拿大安大略省初级保健服务与急诊就诊：基于混合按服务收费和混合定额支付模式的证据
Michael Hong,Rose Anne Devlin,Gregory S Zaric et al.
Michael Hong et al.
Introduction: It is well-known that the way physicians are remunerated can affect delivery of health care services to the population. Fee-for-service (FFS) generally leads to oversupply of services, while capitation leads...
Gianmaria Niccodemi,Govert Bijwaard
Gianmaria Niccodemi
We investigate the association between education and disease-specific medications in old age, prescribed by medical doctors, accounting for confounders and how this association is shaped by intelligence. We use administrative data on men in...
Generating EQ-5D-3L health utility scores from the Edinburgh Postnatal Depression Scale: a perinatal mapping study [0.03%]
基于爱丁堡产后抑郁量表生成EQ-5D-3L健康效用评分：一项围产期映射研究
Elizabeth M Camacho,Gemma E Shields,Carolyn A Chew-Graham et al.
Elizabeth M Camacho et al.
Background: Perinatal depression (PND) describes depression experienced by parents during pregnancy or in the first year after a baby is born. The EQ-5D instrument (a generic measure of health status) is not often collect...
Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin's lymphoma [0.03%]
利图克西试验（B-NHL）的经济学分析：里妥昔单抗治疗儿童及青少年B细胞非霍奇金淋巴瘤的成本效益分析
Béranger Lueza,Anne Aupérin,Charlotte Rigaud et al.
Béranger Lueza et al.
Objectives: The randomized controlled trial Inter-B-NHL ritux 2010 showed overall survival (OS) benefit and event-free survival (EFS) benefit with the addition of rituximab to standard Lymphomes Malins B (LMB) chemotherap...
Referring physicians' intention to use hospital report cards for hospital referral purposes in the presence or absence of patient-reported outcomes: a randomized trial [0.03%]
一项随机试验：有或没有患者报告结果时引荐医生使用医院评价卡进行医院转诊的意愿
Martin Emmert,Anja Schindler,Laura Heppe et al.
Martin Emmert et al.
Purpose: This study aims to determine the intention to use hospital report cards (HRCs) for hospital referral purposes in the presence or absence of patient-reported outcomes (PROs) as well as to explore the relevance of ...
Health impact of borders: general reflections and a case study from the Polish-German border [0.03%]
边境对健康的影响：总体反思及波兰-德国边境的案例研究
Julia Kuntosch,Marie-Luise Ruebsam,Jakub Orsson et al.
Julia Kuntosch et al.
Background and objective: Political, economic, communicative and cultural borders still limit the accessibility of acute healthcare services for patients so that they frequently have to accept longer distances to travel t...
Effect of comorbidities on healthcare expenditures for patients on kidney replacement therapy considering the treatment modality and duration in a French cohort [0.03%]
合并症对法国血液透析和肾移植患者医疗费用的影响分析
Isabella Vanorio-Vega,Panayotis Constantinou,Victor Bret et al.
Isabella Vanorio-Vega et al.
End-stage kidney disease (ESKD) is associated with a substantial economic burden. In France, the cost of care for such patients represents 2.5% of the total French healthcare expenditures but serves less than 1% of the population. These pat...
Response letter for the comment made on our article entitled "Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease", published online last May in the European Journal of Health Economics, doi: 10.1007/s10198-022-01471-9 [0.03%]
关于我刊5月线上发表的题为“纳入社会成本是否改变了多发性硬化病的经济学评价建议？系统综述”的文章的回复信函
Juan Oliva-Moreno
Juan Oliva-Moreno